208 GSK Annual Report 2008 Index Page Page Intellectual property 17 2008 Performance overview 14 Accounting principles and policies 107 Interest rate risk management 49 Internal control framework 71 Acquisitions and disposals 150 Adjustments reconciling profit after tax to operating cash flows 149 Inventories 132 Investments in associates and joint ventures 131 Annual General Meeting 71,204 Annual remuneration 90 Investor relations and Registrar 205 Key accounting judgements and estimates 111 Assets held for sale 133 Associates and joint ventures 121 Key performance indicators 14 Legal proceedings 172 Board 60 Business review 12 Major restructuring programmes 117 Movements in equity 147 Cash and cash equivalents 133 Chairman and CEO summary 3 Nature of trading market 204 Net debt 144 Combined Code 76 Commitments 154 New accounting requirements 112 Non-Executive Director terms, conditions and fees 88 Committee reports 73 Competition 17 Non-Executive Directors remuneration 91 Notes to the financial statements 106 Consolidated balance sheet 103 Consolidated cash flow statement 104 Operating profit 119 Other intangible assets 129 Consolidated income statement 102 Consolidated statement of recognised income and expense 105 Other investments 132 Other non-current assets 132 Consumer Healthcare  Contingent liabilities 144 Other non-current liabilities 144 Other operating income 119 Corporate Executive Team 62 Corporate governance 64 Other provisions 142 Outlook 33 Critical accounting policies 41 Dialogue with shareholders 68 Pensions and other post-employment benefits 134 Directors and Senior Management 98 Performance overview 14 Directors and Senior Management remuneration 89 Pharmaceutical turnover 34 Directors interests 92 Post balance sheet events 155 Directors interests in contracts 98 Presentation of the financial statements 106 Directors statement of responsibilities 100 Principal Group companies 169 Dividends 125 Product development pipeline 24,199 Donations to EU political organisations and EU Products 17 political expenditure 70 Property, plant and equipment 125 Earnings per share 124 Quarterly trend 188 Economy 33 Reconciliation of net cash flow to movement in net debt 150 Employee costs 120 Regulation 32 Employee share schemes 164 Related party transactions 149 Employees 26 Remuneration policy 80-87 Environment, health and safety 30 Remuneration Report 78 Exchange rates 113 Report of the Directors 12 Executive Director terms, conditions and remuneration 87 Research and development 21 Finance costs 121 Responsibility 27 Finance income 120 Risk factors 50 Financial instruments and related disclosures 156 Segment information 114 Financial position and resources 43 Share capital and control 68 Financial record 188 Share capital and share premium account 146 Financial review 2007 54 Share options 92 Financial review 2008 34 Share price and dividends 203 Financial statements of GlaxoSmithKline plc, prepared Shareholder information 203 under UK GAAP 181 Strategy 4 Financial trends and ratios 12 Taxation 122 Five year record 196 Taxation information for shareholders 206 Foreign exchange management 49 Total equity 44 Global manufacturing and supply 20 Trade and other payables 134 Glossary of terms 207 Trade and other receivables 133 Goodwill 127 Trademarks 19 Governance and policy 64 Treasury operations 49 Improving access to medicines 27 US law and regulation 76 Incentive plans 94 World economy 33 Independent Auditors report 101,182 World market 33 GlaxoSmithKline Annual Report 2008 Do more, feel better, live longer Our responsibility Grow Head Office and Registered Office We want to work in a way that reflects our values Deliver GlaxoSmithKline plc and the expectations of our stakeholders.
Ethical, 980 Great West Road social and environmental considerations are integral Brentford, Middlesex TW8 9GS to our business decision making.
They are also central United Kingdom to achieving our challenging and inspiring mission Tel: 44 0 20 8047 5000 of improving the lives of people worldwide.
Simplify Registered number: 3888792 Find out more about our approach to corporate Printed in the UK.
The paper used in responsibility at the production of this document is made from 100% post consumer waste.
com responsibility The pulp is bleached using a totally chlorine free process.
